Business Analytics in Life Sciences

The Time is Ripe for a Technology Revamp in Clinical Trials

USD 3,000.00

* Required Fields

USD 3,000.00


Be the first to review this product

The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in the technology revamp of future clinical trials, which is driven by implementation of effective business analytics solutions, the commoditization of hardware components, and the rise of Internet technologies offering big data analytics.

Table of Contents

Executive SummaryKey FindingsExecutive SummaryCurrent Challenges in Clinical TrialsCurrent ChallengesFallacies of Traditional Patient Recruitment MethodsEHR Data-driven Approaches to Address Challenges in Clinical TrialsEHR Data Use Cases are Expected to EvolveEHR4CR Initiative in Europe Promotes Patient Data Usage in Trials3 Backbones of a Successful Data-driven Approach to Clinical TrialsThe UK is a Forerunner in Terms of Enabling Access to its National EHR Database for Clinical Research PurposesLife Sciences Companies Turn to BA Solutions as Number of Clinical Trials Increase DrasticallyNumber of Clinical Studies has Increased Drastically—Only to Add Complexity and CostsTrial Sponsors are Targeting Clinical Trials for Efficiency GainsRole of BA in Future TrialsKey BA Applications for Clinical TrialsBA Solutions have Moved beyond KPI DashboardsEvolution of Infrastructure Components and Data Repositories has Led to New BI FunctionalitiesInternet and Database Companies have Created New Repositories for Unstructured Data ManagementBI Tools are Empowering Business and End UsersAdvanced Analytics is not just Interactive Displays of InformationFuture of Clinical Trials will Focus on Cost and Process OptimisationComparative Analysis of Key Vendors in BA for Life SciencesRecommendations for Enterprises and VendorsRecommendations for EnterprisesRecommendations for VendorsLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.